Evidence map›Paper›PMID 35034901›Full record

ReviewJournal of Alzheimer's disease : JAD2022

ABCA7, a Genetic Risk Factor Associated with Alzheimer's Disease Risk in African Americans.

Kaitlyn E Stepler, Taneisha R Gillyard, Calla B Reed, Tyra M Avery, Jamaine S Davis, Renã A S Robinson

Open access · greenAbstract readReview
In one paragraph

Review in Journal of Alzheimer's disease : JAD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The ABC's of Alzheimer risk gene ABCA7.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Kaitlyn E SteplerDepartment of Chemistry, Vanderbilt University, Nashville, TN, USA.
Taneisha R GillyardDepartment of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN, USA.
Calla B ReedDepartment of Chemistry, Vanderbilt University, Nashville, TN, USA.
Tyra M AveryDepartment of Life and Physical Sciences, Fisk University, Nashville, TN, USA.
Jamaine S DavisDepartment of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN, USA.
Renã A S RobinsonDepartment of Chemistry, Vanderbilt University, Nashville, TN, USA.
Meharry Medical College · USVanderbilt University · USFisk University · USVanderbilt University Medical Center · US

Funding

The RCMI Program in Health Disparities Research at Meharry Medical College - SupplementU54MD007586 · NIMHD · MEHARRY MEDICAL COLLEGE · PI Samuel Evans Adunyah · 2017 to 2026
$48.2M
Vanderbilt Interdisciplinary Training Program in Alzheimer's DiseaseT32AG058524 · NIA · VANDERBILT UNIVERSITY · PI ANGELA L. JEFFERSON · 2018 to 2026
$3.5M
NIA NIH HHS T32 AG058524NIMHD NIH HHS U54 MD007586
6 · The paper itself

Abstract

African American/Black adults are twice as likely to have Alzheimer's disease (AD) compared to non-Hispanic White adults. Genetics partially contributes to this disparity in AD risk, among other factors, as there are several genetic variants associated with AD that are more prevalent in individuals of African or European ancestry. The phospholipid-transporting ATPase ABCA7 (ABCA7) gene has stronger associations with AD risk in individuals with African ancestry than in individuals with European ancestry. In fact, ABCA7 has been shown to have a stronger effect size than the apolipoprotein E (APOE) ɛ4 allele in African American/Black adults. ABCA7 is a transmembrane protein involved in lipid homeostasis and phagocytosis. ABCA7 dysfunction is associated with increased amyloid-beta production, reduced amyloid-beta clearance, impaired microglial response to inflammation, and endoplasmic reticulum stress. This review explores the impact of ABCA7 mutations that increase AD risk in African American/Black adults on ABCA7 structure and function and their contributions to AD pathogenesis. The combination of biochemical/biophysical and 'omics-based studies of these variants needed to elucidate their downstream impact and molecular contributions to AD pathogenesis is highlighted.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesATP-Binding Cassette TransportersBlack or African AmericanHumansRisk FactorsABCA7 protein, humanAmyloid beta-PeptidesATP-Binding Cassette TransportersAfrican AmericansAlzheimer’s diseaseBlackshealth status disparitieshuman ABCA7 proteinproteomicssingle nucleotide polymorphismsubfamily A of ATP binding cassette transporter

Identifiers

PMID35034901
PMCPMC10984370
OpenAlexW4205713092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.